Paper · 39200219
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression.
Bova V and 12 others. Biomedicines, 2024. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression. Papers, record 39200219. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39200219
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,264,682 | Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells. | Endocr Metab Immune Disord Drug Targets | 2019 | https://conductscience.org/library/papers/30264682 | PubMed |
| 2 | 21,571,321 | Antiproliferative effect of chrysin on anaplastic thyroid cancer. | J Surg Res | 2011 | https://conductscience.org/library/papers/21571321 | PubMed |
| 3 | 37,260,851 | Antiangiogenic Potential of Troxerutin and Chitosan Loaded Troxerutin on Chorioallantoic Membrane Model. | Biomed Res Int | 2023 | https://conductscience.org/library/papers/37260851 | PubMed |
| 4 | 37,750,019 | Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-Myc-mediated glycolysis. | Cancer Sci | 2023 | https://conductscience.org/library/papers/37750019 | PubMed |
| 5 | 27,016,192 | Troxerutin, a natural flavonoid binds to DNA minor groove and enhances cancer cell killing in response to radiation. | Chem Biol Interact | 2016 | https://conductscience.org/library/papers/27016192 | PubMed |
| 6 | 32,523,890 | High Expression of Interleukin-12A and Its Association with the Clinicopathology and Prognosis of Differentiated Thyroid Cancer. | Eur Thyroid J | 2020 | https://conductscience.org/library/papers/32523890 | PubMed |
| 7 | 34,936,296 | Troxerutin Abrogates Ischemic/Reperfusion-Induced Brain Injury through Ameliorating Oxidative Stress and Neuronal Inflammation by Inhibiting the Expression of NLRP3 in Sprague Dawley Rats. | J Environ Pathol Toxicol Oncol | 2021 | https://conductscience.org/library/papers/34936296 | PubMed |
| 8 | 31,177,118 | IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer. | Anticancer Res | 2019 | https://conductscience.org/library/papers/31177118 | PubMed |
| 9 | 33,294,443 | Mechanism by which TRAF6 Participates in the Immune Regulation of Autoimmune Diseases and Cancer. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/33294443 | PubMed |
| 10 | 34,680,471 | Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia. | Biomedicines | 2021 | https://conductscience.org/library/papers/34680471 | PubMed |
1 to 10 of 51
See all 51 referencesCited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,042,696 | Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41042696 | PubMed |
| 39,682,125 | Casein Kinase 2 Inhibitor, CX-4945, Induces Apoptosis and Restores Blood-Brain Barrier Homeostasis in In Vitro and In Vivo Models of Glioblastoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682125 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| HMOX1 | 3,162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| MAP3K14 | 9,020 | PubTator's text mining | https://conductscience.org/library/genes/9020 | NCBI Gene |
| NFKB1 | 4,790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| ROMO1 | 140,823 | PubTator's text mining | https://conductscience.org/library/genes/140823 | NCBI Gene |
| SOD2 | 6,648 | PubTator's text mining | https://conductscience.org/library/genes/6648 | NCBI Gene |
| TRAF6 | 7,189 | PubTator's text mining | https://conductscience.org/library/genes/7189 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39200219
GET https://conductscience.org/api/papers/v1/39200219/references?page=2